A phase I study evaluating COM701 in patients with advanced solid tumors.

被引：0
|
作者：
Rasco, Drew W.
Vaena, Daniel A.
Sullivan, Ryan J.
Luke, Jason J.
ElNaggar, Adam
Hunter, John
Adewoye, Adeboye H.
Olweny, Judy
Patnaik, Amita
Hamilton, Erika Paige
机构：
[1] START, San Antonio, TX USA
[2] West Canc Ctr, Memphis, TN USA
[3] Massachusetts Gen Hosp, Boston, MA 02114 USA
[4] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA
[5] Compugen USA Inc, San Francisco, CA USA
[6] Tennessee Oncol PLLC, Nashville, TN USA
[7] Sarah Cannon Res Inst, Nashville, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.TPS2657
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS2657
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase I trial of cabazitaxel plus cisplatin in patients with advanced solid tumors.
    Lockhart, Albert C.
    Sundaram, Shankar
    Sarantopoulos, John
    Mita, Monica M.
    Lane, Alex R.
    Moseley, Jennifer L.
    Dedieu, Jean-Francois
    Stash, Diane
    Zhi, Xin
    Mazuir, Florent
    Mita, Alain C.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [32] Gemcitabine and Docetaxel in patients with advanced solid tumors. A GETICS phase I trial
    Jaremtchuk, AV
    Zabra, JJ
    Ferro, A
    Aman, EF
    Alvarez, R
    Arroyo, G
    Marmissolle, F
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S290 - S290
  • [33] A phase 1 study of oral navelbine in patients with advanced solid tumors.
    Rajdev, L
    Dai, Q
    Mani, S
    Goldberg, G
    Baker, C
    Hoschander, S
    Sparano, J
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6137S - 6137S
  • [34] A phase I study evaluating CC-4047 in patients with advanced solid tumors
    Nock, C. J.
    Cooney, M. M.
    Mekhail, T.
    Brell, J. M.
    Krishnamurthi, S. S.
    Bokar, J. A.
    Sanborn, S.
    Samsa, J.
    Horvath, N. J.
    Dowlati, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [35] Phase I study of weekly docetaxel and topotecan in the treatment of advanced solid tumors.
    Tan, BR
    Read, W
    Bergeron, K
    Fracasso, PM
    Govindan, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 702S - 702S
  • [36] A phase I study of ARQ 197 in combination with temsirolimus in advanced solid tumors.
    Kyriakopoulos, Christos
    Kolesar, Jill
    Eickhoff, Jens C.
    Heideman, Jennifer
    Liu, Glenn
    Wisinski, Kari Braun
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [37] Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors.
    Rangwala, Fatima A.
    Bendell, Johanna C.
    Kozloff, Mark
    Arrowood, Christy
    Meadows, Jennifer
    Tourt-Uhlig, Sandra Ellen
    Murphy, Jennifer
    Meadows, Kellen
    Morse, Michael
    Uronis, Hope Elizabeth
    Hsu, Shiaowen David
    Zafar, Yousuf
    Hurwitz, Herbert
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [38] A phase I study of pazopanib with weekly paclitaxel and carboplatin in advanced solid tumors.
    Chan, Nancy
    Portal, Daniella E.
    Moss, Rebecca Anne
    Silk, Ann W.
    Stein, Mark N.
    Aisner, Joseph
    Malhotra, Jyoti
    Shih, Weichung
    Lin, Hongxia
    Kane, Michael P.
    Mehnert, Janice M.
    Tan, Antoinette R.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [39] A phase I study of ixabepilone combined with dasatinib in patients with solid tumors.
    Kaiser, C. C.
    Perry, D. J.
    Zimmer, A. S.
    Patterson, J. W.
    Swain, S. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [40] A phase I study of intravenous artesunate (IV AS) in patients with solid tumors.
    Deeken, John F.
    Wang, Hongkun
    Smaglo, Brandon George
    Hwang, Jimmy J.
    He, Aiwu Ruth
    Weiner, Louis M.
    Marshall, John
    Giaccone, Giuseppe
    Liu, Stephen V.
    Luecht, Jim
    Urso, Christina
    Spiegel, Jay Y.
    Cheema, Amrita
    Pishvaian, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345